SANGTER Energy Supplement Capsules Recalled for Undisclosed Sildenafil
Distributor RFR, LLC is recalling SANGTER Energy Supplement Capsules because FDA analysis found they contain undisclosed sildenafil without FDA approval. The product was distributed nationwide and internationally.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification applies. The product is an unapproved drug containing an undisclosed pharmaceutical ingredient (sildenafil) marketed without FDA authorization, meeting the Class I serious health hazard criterion. No deaths or serious injuries are reported in the source.
Plain-English summary
SANGTER Energy Supplement Capsules (3000mg x 7 grain, 7-count blister packs) distributed by Distributor RFR, LLC are being recalled because FDA analysis determined the product contains sildenafil and was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
The recalled product (Lot 48656, expiration 01/2025, UPC 0 705632 523285) was distributed to retail stores in Florida, nationwide in the United States, and internationally through website sales to France, Canada, and the Bolivarian Republic of Venezuela. Approximately 2000 cartons were distributed.
Consumers who purchased this product should discontinue use immediately and consult their healthcare provider. Those with questions or who wish to report adverse events may contact Distributor RFR, LLC at (800) 519-0204 or contact the FDA.
The recalled product
- Product
- SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519-0204 Miami 33172 FL, USA; UPC 0 705632 523285
- Manufacturer
- Distributor RFR, LLC.
- Category
- Drug — Dietary Supplement
- Hazard
- sildenafil
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 48656
- Exp. 01/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27